TABLE 1.
Hospitalization rate (per 100,000) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
First author, year of publication | Country (Data source) | Population | Indication for testing | Included admission diagnosis | Season(s) | Number of hospital inpatients | Population size | Crude | Adjusted a | Dominant influenza strain |
CDC, 2020 42 and Tokars, 2018 24 | United States (FluSurv‐NET) | 50–64 years | Clinician's discretion | Any | 2010–11 | 1205 | 5,499,620 | 21.9 | 86.1 | A(H3N2) |
2011–12 | 432 | 5,346,197 | 8.1 | 33.1 | A(H3N2) | |||||
2012–13 | 2210 | 5,430,213 | 40.7 | 151.7 | A(H3N2) | |||||
2013–14 | 2845 | 5,296,266 | 53.7 | 137.9 | A(H1N1) | |||||
2014–15 | 2871 | 5,372,656 | 53.4 | 137.2 | A(H3N2) | |||||
2015–16 | 2450 | 5,372,656 | 45.1 | 117.1 | A(H1N1) | |||||
2016–17 | N/A | N/A | 62.7 | A(H3N2) | ||||||
2017–18 | N/A | N/A | 112.8 | A(H3N2) | ||||||
2018–19 | N/A | N/A | 79.2 | A(H3N2) | ||||||
2019–20 | N/A | N/A | 89.4 | A(H3N2) | ||||||
Hughes, 2019 25 | United States, Utah | 50–64 years | Clinician's discretion | Any | 2016–17 | N/A | N/A | 56 | 91 | N/A |
2017–18 | N/A | N/A | 87 | 142 | N/A | |||||
Leng, 2018 26 | Cambodia | 50–64 years | SARI b | Not described | 2015 | 5 | 30,991 | 16.1 | A(H3N2) | |
2016 | 28 | 62,290 | 44.9 | A(H1N1) & B | ||||||
Yu, 2014 27 | China | 45–64 years | SARI c | Not described | 2010–11 | 134 | 224,903 | 60 | N/A | |
2011–12 | 56 | 224,903 | 25 | N/A | ||||||
PHAC, 2020 43 | Canada (FluWatch) | 45–64 years | Clinician's discretion | Symptoms compatible with influenza | 2013–14 | N/A | N/A | 29 | A(H1N1) | |
2014–15 | N/A | N/A | 16 | A(H3N2) | ||||||
2015–16 | N/A | N/A | 37 | A(H1N1) | ||||||
2016–17 | N/A | N/A | 22 | A(H3N2) | ||||||
2017–18 | N/A | N/A | 41 | A(H3N2) | ||||||
2018–19 | N/A | N/A | 40 | A(H1N1) | ||||||
2019–20 | N/A | N/A | 23 | A(H1N1) |
Abbreviations: CDC, Centre for Disease Control and Prevention; ICD‐10, International Classification of Diseases Tenth Revision; N/A, not available; PHAC, Public Health Agency of Canada; SARI, severe acute respiratory illness.
Tokars and Hughes adjusted rates for the age group‐specific percentage of hospital inpatients with respiratory disease that were tested for influenza and the sensitivity and specificity of laboratory methods used.
Fever or history of fever (≥38°C), cough or sore throat, and shortness of breath or difficulty breathing in a hospitalized person with onset of symptoms within 10 days before hospitalization.
Rectal or axillary temperature ≥37.3°C and at least one of cough, sore throat, tachypnea, difficulty breathing, abnormal breath sounds on auscultation, sputum production, hemoptysis, chest pain, or chest radiograph consistent with pneumonia.